Isosulfan Blue: Side Effects, Uses & Monitoring
Isosulfan Blue 1% Injection delineates the lymphatic vessels following subcutaneous administration.
- Data source
- FDA labeling via NIH DailyMed (label b0f9b119…)
- Label version
- current
- Last reviewed
- 2026
Reported adverse reactions
Reactions listed in current FDA labeling, with the highest frequency reported across summarized placebo-controlled trials.
No structured frequency data available in current labeling. Consult the official label.
Labeled uses (from FDA prescribing information)
Isosulfan Blue 1% Injection delineates the lymphatic vessels following subcutaneous administration. It is an adjunct to lymphography (in primary and secondary lymphedema of the extremities; chyluria, chylous ascites or chylothorax; lymph node involvement by primary or secondary neoplasm; and lymph node response to therapeutic modalities) for visualization to the lymphatic system draining the region of injection
Frequently Asked Questions
What is Isosulfan Blue used for?
FDA labeling lists the approved uses shown above under "Labeled uses." This summary is informational; only a qualified prescriber can determine whether a medication is appropriate for you.
What are the most commonly reported side effects of Isosulfan Blue?
Current labeling for this ingredient does not include a structured frequency table that we can reproduce. Review the official label linked below.
Does Isosulfan Blue require lab monitoring?
Monitoring needs vary. Ask your healthcare provider whether any lab tests apply while taking Isosulfan Blue.
Where does this information come from?
All clinical facts on this page were extracted from the current FDA-registered product labeling for this ingredient, published by manufacturers through NIH DailyMed. See the source link below.
Medical disclaimer: Educational content extracted from public FDA labeling. Not medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.